Mark Skaletsky (Chairman)
Chairman and Chief Executive Officer, Fenway Pharmaceuticals
Newton, MA

M. James Barrett, Ph.D.
General Partner, New Enterprise Associates
Baltimore, MD

Charles A. Blixt, Esq.
Former General Counsel, Reynolds American (Retired)
Winston-Salem, NC

Julia R. Brown
Former Executive Vice President and Advisor to the CEO, Amylin Pharmaceuticals (Retired)
San Diego, CA

G. Steven Burrill
Chief Executive Officer,  Burrill & Company, LLC
San Francisco, CA

J. Donald deBethizy, Ph.D.
President and Chief Executive Officer, Targacept
Winston-Salem, NC

Errol B. De Souza, Ph.D.
President and Chief Executive Officer, Biodel Inc.
Danbury, CT 

Alan W. Dunton, M.D.
Pharmaceutical/Biotechnology Consultant, Danerius
Cambridge, MA

John P. Richard
Managing Director, Georgia Venture Partners
Atlanta, GA

Ralph Snyderman, M.D.
Chancellor Emeritus and James B. Duke Professor of Medicine, Duke University
Durham, NC